glp-1 weight loss effectiveness with medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans An experimental investigation of the

In a major clinical trial published in The New England Journal of Medicine , patients taking retatrutide lost an average of about 24% of their body weight after 48 weeks

The MycoTOX Profile is designed to accurately detect mycotoxins produced by various toxic molds

Consistently, soluble A microinjected into the parenchyma (Fig

Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin

On the contrary, excessive ROS levels cause cell injury by damaging proteins, lipids, and nucleic acids, leading to different conditions, such as neurological diseases, hypertension, diabetes, atherosclerosis, heart failure, chronic kidney disease, and cancerogenesis [2]